115 related articles for article (PubMed ID: 29037140)
1. Blockade of Interleukin 6 by Rat Anti-mouse Interleukin 6 Receptor Antibody Promotes Fracture Healing.
Huang L; Liu S; Song T; Zhang W; Fan J; Liu Y
Biochemistry (Mosc); 2017 Oct; 82(10):1193-1199. PubMed ID: 29037140
[TBL] [Abstract][Full Text] [Related]
2. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures.
Giganti MG; Liuni F; Celi M; Gasbarra E; Zenobi R; Tresoldi I; Modesti A; Bei R; Tarantino U
J Biol Regul Homeost Agents; 2012; 26(4):671-80. PubMed ID: 23241117
[TBL] [Abstract][Full Text] [Related]
4. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K
BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103
[TBL] [Abstract][Full Text] [Related]
5. TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose.
Sun M; Yang J; Wang J; Hao T; Jiang D; Bao G; Liu G
Cytokine; 2016 Apr; 80():35-42. PubMed ID: 26945994
[TBL] [Abstract][Full Text] [Related]
6. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
7. Blockade of interleukin-6 receptor enhances the anti-arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen-induced arthritis.
Suzuki M; Yoshida H; Hashizume M; Tanaka K; Matsumoto Y
Clin Exp Immunol; 2015 Nov; 182(2):154-61. PubMed ID: 26201536
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture.
Lee JS; Ryu CH; Moon NH; Kim SJ; Park SY; Suh KT
Arch Orthop Trauma Surg; 2009 May; 129(5):711-8. PubMed ID: 18427820
[TBL] [Abstract][Full Text] [Related]
9. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
10. Characterization of anti-mouse interleukin-6 receptor antibody.
Okazaki M; Yamada Y; Nishimoto N; Yoshizaki K; Mihara M
Immunol Lett; 2002 Dec; 84(3):231-40. PubMed ID: 12413742
[TBL] [Abstract][Full Text] [Related]
11. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
12. Effects of interleukin-6 blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Mori K; Yoshida K; Mihara M; Ohsugi Y; Nakagawa Y; Hoshikawa S; Ozaki H; Ito S
Autoimmunity; 2009 Mar; 42(3):228-34. PubMed ID: 19301205
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
14. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice.
Mihara M; Nishimoto N; Yoshizaki K; Suzuki T
Immunol Lett; 2002 Dec; 84(3):223-9. PubMed ID: 12413741
[TBL] [Abstract][Full Text] [Related]
15. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
16. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice.
Yoshida H; Hashizume M; Suzuki M; Mihara M
Rheumatol Int; 2011 Nov; 31(11):1445-9. PubMed ID: 20473503
[TBL] [Abstract][Full Text] [Related]
17. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice.
Mihara M; Takagi N; Takeda Y; Ohsugi Y
Clin Exp Immunol; 1998 Jun; 112(3):397-402. PubMed ID: 9649207
[TBL] [Abstract][Full Text] [Related]
18. [Infiltration of macrophages and their phenotype in the healing process of full-thickness wound in rat].
Niu Y; Miao M; Cao X; Song F; Ji X; Dong J; Lu S
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):109-15. PubMed ID: 24989654
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion.
Hartman MH; Vreeswijk-Baudoin I; Groot HE; van de Kolk KW; de Boer RA; Mateo Leach I; Vliegenthart R; Sillje HH; van der Harst P
PLoS One; 2016; 11(12):e0167195. PubMed ID: 27936014
[TBL] [Abstract][Full Text] [Related]
20. Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Hashimoto K
Transl Psychiatry; 2017 May; 7(5):e1138. PubMed ID: 28556833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
